Abstract:Titanium and titanium-based alloys are widely used in orthopaedic implants. Total joint replacement is very successful; however, the foreign body response and chronic inflammation caused by implant-derived biomaterial debris still remain as unsolved issues. Aseptic loosening accompanied by wear debris-induced osteolysis (bone loss) is one of the most frequent causes for late failure and revision surgery. Mesenchymal stem cells (MSCs) and IL-4 may be possible treatment strategies because of their immunomodulatory properties. We investigated the efficacy of novel MSC-based treatments on immunomodulation and osteogenic differentiation in an innovative cell coculture model of titanium particle-induced inflammation in the periprosthetic tissues. MSCs and macrophages were collected from the bone marrow of Balb/c mice. Both MSCs and macrophages (representing endogenous cells at the periprosthetic tissue) were seeded on the bottom wells of the 24-well transwell plates. We generated genetically modified NF-κB sensing IL-4 secreting MSCs (inflammatory responsive MSCs) and MSCs preconditioned by lipopolysaccharide and TNF-α to further enhance their immunomodulatory function. These modified MSCs (representing exogenous therapeutic cells implanted to the periprosthetic tissue) were seeded on the upper chambers of the transwell plates. These cocultures were then exposed to titanium particles for 7 days. NF-κB sensing IL-4 secreting MSCs showed strong immunomodulation (significantly reduced TNF-α and induced Arg1 expression) and promoted early osteogenesis (significantly induced Runx2, ALP, and β-catenin as well as reduced Smurf2 expression) at day 7. IL-4 secreting MSCs also decreased TNF-α protein secretion as early as day 3 and increased IL-1ra protein secretion at day 7, suggesting efficacious immunomodulation of particle-induced inflammation. Preconditioned MSCs did not show significant immunomodulation in this short-term experiment, but ALP and β-catenin expression were significantly induced at day 7. Our results suggest that genetically modified IL-4 secreting MSCs and preconditioned MSCs have the potential to optimize bone regeneration in inflammatory conditions including periprosthetic osteolysis.

Mutant Ccl2 Protein Coating Mitigates Wear Particle-Induced Bone Loss in A Murine Continuous Polyethylene Infusion Model

Mutant MCP-1 Protein Delivery from Layer-by-layer Coatings on Orthopedic Implants to Modulate Inflammatory Response

Local Delivery of Mutant CCL2 Protein‐reduced Orthopaedic Implant Wear Particle‐induced Osteolysis and Inflammation in Vivo

Platelet-Derived Growth Factor-Bb Attenuates Titanium-Particle-Induced Osteolysis in Vivo

The Effect of Local IL‐4 Delivery or CCL2 Blockade on Implant Fixation and Bone Structural Properties in a Mouse Model of Wear Particle Induced Osteolysis

Effect of 15-Deoxy-Δ 12,14 -prostaglandin J 2 Nanocapsules on Inflammation and Bone Regeneration in a Rat Bone Defect Model.

Is there another possible approach to inhibit wear particles-induced inflammatory osteolysis?

Mesenchymal Stem Cells and NF-κB Sensing Interleukin-4 Over-Expressing Mesenchymal Stem Cells Are Equally Effective in Mitigating Particle-Associated Chronic Inflammatory Bone Loss in Mice

Effects of Local and Systemic Alendronate Delivery on Wear Debris-Induced Osteolysis in Vivo

Protection against titanium particle induced osteolysis by cannabinoid receptor 2 selective antagonist.

Treating Titanium Particle-Induced Inflammation with Genetically Modified NF- κ B Sensing IL-4 Secreting or Preconditioned Mesenchymal Stem Cells in Vitro

Calcineurin/NFAT signaling pathway mediates titanium particle‑induced inflammation and osteoclast formation by inhibiting RANKL and M‑CSF in vitro

Mutant Monocyte Chemoattractant Protein-1 Protein (7ND) Inhibits Osteoclast Differentiation and Reduces Oral Squamous Carcinoma Cell Bone Invasion

Lithium chloride with immunomodulatory function for regulating titanium nanoparticle-stimulated inflammatory response and accelerating osteogenesis through suppression of MAPK signaling pathway.

BMP-2 functional polypeptides relieve osteolysis via bi-regulating bone formation and resorption coupled with macrophage polarization

Tanshinone Iia Protects Against Polyethylene Particle-Induced Osteolysis Response In A Mouse Calvarial Model

Niobium Carbide (mxene) Reduces UHMWPE Particle-Induced Osteolysis

Mangiferin- and GNPs/ECPP-loaded Platform of UH with Dual Bi-Directional Dynamic Modulation of Stem Cells/macrophages and Osteoblasts/osteoclasts for the Prevention of Aseptic Loosening.

Mangiferin, GNPs/ECPP-loaded platform of UH with dual bi-directional dynamic modulation of stem cells/macrophages, osteoblasts/osteoclasts for the prevention of aseptic loosening

Mmp-9 Inhibition Suppresses Wear Debris-Induced Inflammatory Osteolysis Through Downregulation Of Rank/Rankl In A Murine Osteolysis Model

MgO Nanoparticles Protect against Titanium Particle-Induced Osteolysis in a Mouse Model Because of Their Positive Immunomodulatory Effect